Analyst Ratings for Silence Therapeutics (SLN)
SLN Rating Summary
SLN Price Target Summary
- Highest: $32.00 (Morgan Stanley)
- Lowest: $20.00 (Chardan)
- Average: $25.67
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$25.67 (+30.5%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
Avg. $ Target:
$25.67 (+30.5%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/21/2026 | H.C. Wainwright | Patrick Trucchio | Downgrade | Neutral (Buy) |
N/A (N/A) |
19.61 (19.67) |
0.31% | Details |
| 10/19/2026 | William Blair | Myles Minter | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
8.68 (19.67) |
126.61% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
